JUST IN: NAFDAC Approves Oxford-AstraZeneca COVID-19 Vaccine For Use In Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria.
The vaccine was recently approved by the W.H.O for emergency use.
However, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
Comments are closed.